MedImmune, Inc. Recognized by Local Volunteer Organization for Its Employees’ Exceptional Commitment to Community Service within Montgomery County

GAITHERSBURG, Md., Oct. 24 /PRNewswire/ -- MedImmune, Inc. announced today that the Corporate Volunteer Council of Montgomery County (CVC-MC) has recognized the company for its employees’ exceptional commitment to the community. MedImmune received the CVC-MC’s 2007 Corporate Volunteer Award for a large business.

“As the region’s leading biotechnology company, MedImmune is proud to serve as an outstanding corporate citizen whose employees strive to give back to the community. It is exciting that the CVC-MC has recognized our employees’ dedication to improving Montgomery County,” said Toni Stiefel, director, internal communications and community relations. “This dedication not only benefits our community, but also helps to foster a positive corporate culture and work environment.”

MedImmune encourages employees to contribute meaningfully to the communities where its employees work and live. As a company dedicated to advancing science for better health, MedImmune engages its employees in volunteer and community outreach activities that help to improve health and to advance science education.

Each year, the CVC-MC recognizes one small, medium-sized, and large business for community service programs that positively impact the business, its employees and the local community. More information about the CVC-MC is available at www.cvc-mc.org.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is dedicated to advancing science and medicine to help people live better lives and is wholly owned by AstraZeneca plc . For more information, visit MedImmune’s website at http://www.medimmune.com.

CONTACT: Jamie Lacey of MedImmune, +1-301-398-4035

Web site: http://www.medimmune.com/
http://www.cvc-mc.org/

MORE ON THIS TOPIC